Wenjing Zhitong Decoction Alleviates Primary Dysmenorrhea Mediated by Pain Sensitization Via the ERα‐BDNF Signaling Pathway
Open Access
- 1 January 2025
- journal article
- Published by Wiley in Journal of Clinical Pharmacy and Therapeutics
- Vol. 2025 (1)
Abstract
Background: Wen‐Jing‐Zhi‐Tong decoction (WJZTD) is a traditional Chinese medicine herbal decoction that has demonstrated clinical efficacy in treating primary dysmenorrhea (PDM) over decades. However, the underlying therapeutic mechanism of WJZTD requires further clarification. Objective: This study aims to explore and elucidate the therapeutic mechanism of WJZTD in treating PDM through metabolomics, integrated network pharmacology, as well as in vitro and in vivo experiments. Methods: A PDM rat model was established by estradiol benzoate and oxytocin for 3 consecutive estrous cycles, and then WJZTD treatment was administered for 3 consecutive estrous cycles. To evaluate the therapeutic effect of WJZTD on PDM, behavioral tests, histological analysis, and evaluation of serum prostaglandins (PGs) were performed. Moreover, immunofluorescence and Western blot analysis were carried out in dorsal root ganglion (DRG) tissues to explore the role of WJZTD in reducing pain sensitivity. Metabolomics and integrated pharmacology were utilized to identify potential bioactive targets, which were then validated through in vitro experiments. Results: WJZTD significantly reduces pain sensitivity in PDM rats, treating the condition effectively by decreasing brain‐derived neurotrophic factor (BDNF) protein expression, c‐Fos‐positive neurons in DRG, and serum prostaglandin PGF2α (PGF2α) levels. A nontargeted metabolic analysis identified 11 differential metabolites, suggesting ESR1 (estrogen receptor α, ERα) as a potential target. In vitro experiments confirmed WJZTD’s efficacy in treating PDM through regulating the ERα/BDNF signaling pathway. Conclusion: WJZTD decreases the excitability of DRG neurons in rats with PDM through the ERα/BDNF pathway, which enhances pain sensitization and contributes to reducing dysmenorrhea.Keywords
Funding Information
- National Natural Science Foundation of China (81973898)
This publication has 66 references indexed in Scilit:
- Preoperative pain sensitivity and its correlation with postoperative acute and chronic pain: a systematic review and meta-analysisBritish Journal of Anaesthesia, 2024
- Murine Models and Research Progress on DysmenorrheaReproductive Sciences, 2023
- BDNF signaling in context: From synaptic regulation to psychiatric disordersCell, 2021
- Leptin Contributes to Neuropathic Pain via Extrasynaptic NMDAR-nNOS ActivationMolecular Neurobiology, 2020
- Diagnosis and Management of Primary DysmenorrheaJAMA, 2020
- Ablation of spinal cord estrogen receptor α‐expressing interneurons reduces chemically induced modalities of pain and itchJournal of Comparative Neurology, 2019
- Women with dysmenorrhoea are hypersensitive to experimentally induced forearm ischaemia during painful menstruation and during the pain‐free follicular phaseEuropean journal of pain, 2014
- Brain‐derived neurotrophic factor modulates antiretroviral‐induced mechanical allodynia in the mouseJournal of Neuroscience Research, 2011
- Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a reviewContraception, 2010
- Estrogen receptor‐α and ‐β immunoreactive neurons in the brainstem and spinal cord of male and female mice: Relationships to monoaminergic, cholinergic, and spinal projection systemsJournal of Comparative Neurology, 2005